Tessera
Folgen

A/Prof Qingwei Luo

@qingweiluo.bsky.social

Associate Professor, The Daffodil Centre, The University of Sydney, and Cancer Council NSW

1 Posts21 Follower16 Folgt
A/Prof Qingwei Luo@qingweiluo.bsky.social · 10mo ago

We’re thrilled to have our linked comment published in @thelancet.com The future of cancer control depends on decisive, collective action today. 🔗 Read it here: doi.org/10.1016/S014... 📄 Original article: doi.org/10.1016/S014... @daffodilcentre.org @sydney.edu.au

Redirecting

doi.org

The Lancet@thelancet.com · 10mo ago

Cancer deaths expected to rise to over 18 million in 2050—an increase of nearly 75% from 2024, study forecasts. Explore the data ▶️ tinyurl.com/5n7dfnws @ihmeuw.bsky.social #NCDs

Figure: Global age-specific cancer (A) incidence and (B) mortality in 2023 for all sexes combined. Results are presented by 5-year age group. Left panels present age-specific incidence and mortality rates. Right panels present age-specific new case and death proportions. Copyright: 2025 Elsevier Ltd. All rights are reserved.
The Lancet Regional Health - Western Pacific@lancetrh-wpac.bsky.social · last yr.

🆕 First long-term #projections for #cancer prevalence associated with key #PanTumour #biomarkers in #Australia to 2042, to inform health policy & planning for targeted therapies. #MedSky #OncSky @daffodilcentre.bsky.social @juliasteinberg.bsky.social @qingweiluo.bsky.social 🔗Check out full text!

Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042

We present the first long-term projections for cancer prevalence associated with key pan-tumour biomarkers in Australia, to inform health policy and healthcare planning for targeted therapies.

thelancet.com